OBJECTIVE: To experimentally test whether using pictographs (image matrices), incremental risk formats, and varied risk denominators would influence perceptions and comprehension of side effect risks in an online decision aid about prophylactic use of tamoxifen to prevent primary breast cancers. METHODS: We recruited 631 women with elevated breast cancer risk from two healthcare organizations. Participants saw tailored estimates of the risks of 5 side effects: endometrial cancer, blood clotting, cataracts, hormonal symptoms, and sexual problems. Presentation format was randomly varied in a three factor design: (A) risk information was displayed either in pictographs or numeric text; (B) presentations either reported total risks with and without tamoxifen or highlighted the incremental risk most relevant for decision making; and (C) risk estimates used 100 or 1000 person denominators. Primary outcome measures included risk perceptions and gist knowledge. RESULTS: Incremental risk formats consistently lowered perceived risk of side effects but resulted in low knowledge when displayed by numeric text only. Adding pictographs, however, produced significantly higher comprehension levels. CONCLUSIONS: Pictographs make risk statistics easier to interpret, reducing biases associated with incremental risk presentations. PRACTICE IMPLICATIONS: Including graphs in risk communications is essential to support an informed treatment decision-making process.
RCT Entities:
OBJECTIVE: To experimentally test whether using pictographs (image matrices), incremental risk formats, and varied risk denominators would influence perceptions and comprehension of side effect risks in an online decision aid about prophylactic use of tamoxifen to prevent primary breast cancers. METHODS: We recruited 631 women with elevated breast cancer risk from two healthcare organizations. Participants saw tailored estimates of the risks of 5 side effects: endometrial cancer, blood clotting, cataracts, hormonal symptoms, and sexual problems. Presentation format was randomly varied in a three factor design: (A) risk information was displayed either in pictographs or numeric text; (B) presentations either reported total risks with and without tamoxifen or highlighted the incremental risk most relevant for decision making; and (C) risk estimates used 100 or 1000 person denominators. Primary outcome measures included risk perceptions and gist knowledge. RESULTS: Incremental risk formats consistently lowered perceived risk of side effects but resulted in low knowledge when displayed by numeric text only. Adding pictographs, however, produced significantly higher comprehension levels. CONCLUSIONS: Pictographs make risk statistics easier to interpret, reducing biases associated with incremental risk presentations. PRACTICE IMPLICATIONS: Including graphs in risk communications is essential to support an informed treatment decision-making process.
Authors: M H Gail; L A Brinton; D P Byar; D K Corle; S B Green; C Schairer; J J Mulvihill Journal: J Natl Cancer Inst Date: 1989-12-20 Impact factor: 13.506
Authors: Angela Fagerlin; David Rovner; Sue Stableford; Christophir Jentoft; John T Wei; Margaret Holmes-Rovner Journal: Ann Intern Med Date: 2004-05-04 Impact factor: 25.391
Authors: A M O'Connor; D Stacey; V Entwistle; H Llewellyn-Thomas; D Rovner; M Holmes-Rovner; V Tait; J Tetroe; V Fiset; M Barry; J Jones Journal: Cochrane Database Syst Rev Date: 2003
Authors: Michael L Volk; Rachel S Tocco; Shawn J Pelletier; Brian J Zikmund-Fisher; Anna S F Lok Journal: Liver Transpl Date: 2011-12 Impact factor: 5.799
Authors: Helen W Sullivan; Amie C O'Donoghue; Kathryn J Aikin; Dhuly Chowdhury; Rebecca R Moultrie; Douglas J Rupert Journal: Patient Educ Couns Date: 2015-12-22
Authors: Peter A Ubel; Dylan M Smith; Brian J Zikmund-Fisher; Holly A Derry; Jennifer McClure; Azadeh Stark; Cheryl Wiese; Sarah Greene; Aleksandra Jankovic; Angela Fagerlin Journal: Patient Educ Couns Date: 2009-12-09
Authors: Angela Fagerlin; Brian J Zikmund-Fisher; Vijayan Nair; Holly A Derry; Jennifer B McClure; Sarah Greene; Azadeh Stark; Sharon Hensley Alford; Paula Lantz; Daniel F Hayes; Cheryl Wiese; Sarah Claud Zweig; Rosemarie Pitsch; Aleksandra Jankovic; Peter A Ubel Journal: Breast Cancer Res Treat Date: 2010-02 Impact factor: 4.872